Group 1 - The core viewpoint of the article is that Guoen Technology, a Chinese chemical materials supplier, has successfully completed its IPO subscription, raising significant interest from investors with an oversubscription of 878 times the public offering amount [1] - Guoen Technology plans to issue 30 million H-shares, with 10% allocated for Hong Kong and 90% for international offerings, and a total fundraising target of up to HKD 1.26 billion [1] - The company has attracted eight cornerstone investors, with a total subscription amount of approximately HKD 320 million [1] Group 2 - Guoen Technology, founded in 2000, specializes in chemical new materials and gelatin, serving both the chemical and health industries [2] - The company is the second-largest producer of bone gelatin in China and the largest domestic brand in terms of production volume, as well as the second-largest domestic brand in the hollow capsule industry [2] - Financially, the company reported revenues of approximately RMB 134.06 billion, RMB 174.39 billion, RMB 191.88 billion, and RMB 174.44 billion for the fiscal years 2022, 2023, 2024, and the first ten months of 2025, respectively [2] Group 3 - The net proceeds from the IPO are expected to be approximately HKD 1.058 billion, with 50% allocated to expanding production capacity in Thailand, 35% for new production capacity in China, 10% for investments in Hong Kong, and 5% for operational funds and general corporate purposes [3]
新股消息 | 国恩科技(02768)结束招股 孖展认购额录得1107.6亿港元 超购878倍